Search

Author/Creator Mullighan, Charles G.

1. Activating killer‐cell immunoglobulin‐like receptor haplotype influences clinical outcome following HLA‐matched sibling haematopoietic stem cell transplantation. (20th August 2018)

Authors:
Heatley, Susan L.; Mullighan, Charles G.; Doherty, Kathleen; Danner, Silke; O'Connor, Geraldine M.; Hahn, Uwe; Szer, Jeff; Schwarer, Anthony; Bradstock, Kenneth; Sullivan, Lucy C.; Bardy, Peter G.; Brooks, Andrew G.
Journal:
HLA
Issue:
Volume 92:Number 2(2018)
Page Start:
74
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA Sequencing. (20th April 2022)

Authors:
Wang, Jeremy; Bhakta, Nickhill; Ayer Miller, Vanessa; Revsine, Mahler; Litzow, Mark R.; Paietta, Elisabeth; Fedoriw, Yuri; Roberts, Kathryn G.; Gu, Zhaohui; Mullighan, Charles G.; Jones, Corbin D.; Alexander, Thomas B.
Journal:
JCO precision oncology
Issue:
Volume 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Analytical demands to use whole-genome sequencing in precision oncology. (September 2022)

Authors:
Meggendorfer, Manja; Jobanputra, Vaidehi; Wrzeszczynski, Kazimierz O.; Roepman, Paul; de Bruijn, Ewart; Cuppen, Edwin; Buttner, Reinhard; Caldas, Carlos; Grimmond, Sean; Mullighan, Charles G.; Elemento, Olivier; Rosenquist, Richard; Schuh, Anna; Haferlach, Torsten
Journal:
Seminars in cancer biology
Issue:
Volume 84(2022)
Page Start:
16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial. (27th March 2020)

Authors:
Ganzel, Chezi; Wang, Xin V.; Rowe, Jacob M.; Richards, Susan M.; Buck, Georgina; Marks, David I.; Litzow, Mark R.; Paietta, Elisabeth M.; Foroni, Letizia; Luger, Selina M.; Willman, Cheryl L.; Mullighan, Charles G.; Roberts, Kathryn G.; Wiernik, Peter H.; Douer, Dan; Lazarus, Hillard M.; Tallman,...
Journal:
British journal of haematology
Issue:
Volume 191:Number 1(2020)
Page Start:
37
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Characterisation of children and adolescents with acute lymphoblastic leukaemia who presented without peripheral blood blasts at diagnosis. (9th November 2022)

Authors:
Mangum, David Spencer; Bishop, Johnathon D.; Zhou, Yinmei; Cheng, Cheng; Karol, Seth E.; Rubnitz, Jeffrey E.; Ribeiro, Raul C.; Yang, Jun J.; Mullighan, Charles G.; Jeha, Sima; Pui, Ching‐Hon; Inaba, Hiroto
Journal:
British journal of haematology
Issue:
Volume 200:Number 3(2023)
Page Start:
338
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665. Issue 10 (2nd October 2016)

Authors:
DeBoer, Rebecca; Koval, Gregory; Mulkey, Flora; Wetzler, Meir; Devine, Steven; Marcucci, Guido; Stone, Richard M.; Larson, Richard A.; Bloomfield, Clara D.; Geyer, Susan; Mullighan, Charles G.; Stock, Wendy
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 10(2016:Oct.)
Page Start:
2298
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Clinical utility of whole-genome sequencing in precision oncology. (September 2022)

Authors:
Rosenquist, Richard; Cuppen, Edwin; Buettner, Reinhard; Caldas, Carlos; Dreau, Helene; Elemento, Olivier; Frederix, Geert; Grimmond, Sean; Haferlach, Torsten; Jobanputra, Vaidehi; Meggendorfer, Manja; Mullighan, Charles G.; Wordsworth, Sarah; Schuh, Anna
Journal:
Seminars in cancer biology
Issue:
Volume 84(2022)
Page Start:
32
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts. Issue 1 (January 2021)

Authors:
Janke, Laura J.; Imai, Denise M.; Tillman, Heather; Doty, Rosalinda; Hoenerhoff, Mark J.; Xu, Jiajie J.; Freeman, Zachary T.; Allen, Portia; Fowlkes, Natalie Wall; Iacobucci, Ilaria; Dickerson, Kirsten; Mullighan, Charles G.; Vogel, Peter; Rehg, Jerold E.
Journal:
Veterinary pathology
Issue:
Volume 58:Issue 1(2021)
Page Start:
181
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Epigenetic silencing of SOCS5 potentiates JAK‐STAT signaling and progression of T‐cell acute lymphoblastic leukemia. Issue 6 (3rd May 2019)

Authors:
Sharma, Nitesh D.; Nickl, Christian K.; Kang, Huining; Ornatowski, Wojciech; Brown, Roger; Ness, Scott A.; Loh, Mignon L.; Mullighan, Charles G.; Winter, Stuart S.; Hunger, Stephen P.; Cannon, Judy L.; Matlawska‐Wasowska, Ksenia
Journal:
Cancer science
Issue:
Volume 110:Issue 6(2019)
Page Start:
1931
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗